Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000919574-25-003576
Filing Date
2025-06-12
Accepted
2025-06-12 21:17:19
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 12742
2 d11817440_ex99-a.htm EX-99 6205
3 d11817440_ex99-b.htm EX-99 12955
  Complete submission text file 0000919574-25-003576.txt   33651
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Subject) CIK: 0001819253 (see all company filings)

EIN.: 851791125 | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-92341 | Film No.: 251044579
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address 767 THIRD AVE 29TH FLOOR NEW YORK NY 10017
Business Address 767 THIRD AVE 29TH FLOOR NEW YORK NY 10017 212-326-6010
Roystone Management Holdings LLC (Filed by) CIK: 0002062000 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D